Logout
If you want to log out click in LogOut
Explore peer-reviewed qPCR publications and qPCR array publications using AnyGenes® products and services across oncology, inflammation, cardiovascular research, lncRNA analysis, microbiome studies, oxidative stress, apoptosis, RNA-seq validation and biomarker discovery.
AnyGenes® qPCR assays, SignArrays® qPCR arrays, validated primer sets, lncRNA panels and biomarker solutions have supported a wide range of scientific studies, helping research teams generate targeted gene expression data, validate molecular signatures and explore biologically relevant pathways.
This bibliography highlights selected publications where AnyGenes® solutions contributed to gene expression analysis, pathway-focused qPCR profiling, biomarker validation or translational research.
Choosing a qPCR solution is not only a technical decision. For many research teams, it also requires confidence in assay specificity, reproducibility, biological relevance and suitability for publication-ready results.
The scientific publications listed on this page illustrate how AnyGenes® products and services have been used in real research contexts, including academic, clinical and translational studies.
These publications cover multiple applications, including:
The publication list currently includes studies from 2009 to 2024, covering areas such as cancer, inflammation, oxidative stress, lncRNA research, microbiome analysis, cardiovascular diseases, pulmonary hypertension and transcriptomic validation.
AnyGenes® SignArrays® qPCR arrays are designed to help researchers analyze targeted biological pathways using focused gene expression panels.
In published studies, pathway-focused qPCR analysis can support different research objectives, such as identifying dysregulated signaling pathways, validating candidate biomarkers, confirming RNA-seq results or comparing biological responses between experimental conditions.
AnyGenes® qPCR array publications are particularly relevant for research areas such as:
AnyGenes® products and services have been used in publications focused on melanoma, glioblastoma, prostate cancer, lung cancer, renal cell carcinoma, breast cancer, oral cancer, sarcoma and other tumor models.
These studies include research on tumor progression, invasion, angiogenesis, treatment resistance, apoptosis, immune response, oncogenic pathways and molecular biomarkers.
Relevant AnyGenes® solutions:
Several qPCR publications using AnyGenes® solutions investigate inflammatory pathways, immune activation, oxidative stress, apoptosis and tissue responses in different experimental models.
These studies are relevant for researchers working on inflammation, toxicology, aging, metabolic disease, pulmonary research and immune-related disorders.
Relevant AnyGenes® solutions:
AnyGenes® lncRNA-related solutions support targeted quantification of long non-coding RNAs and other non-coding RNA candidates identified through RNA-seq, literature mining or disease-focused research.
These qPCR publications are particularly relevant for teams studying disease-associated lncRNAs, validating RNA-seq results or building targeted qPCR panels for non-coding RNA analysis.
Relevant AnyGenes® solutions:
AnyGenes® solutions have contributed to publications in cardiovascular and pulmonary research, including pulmonary arterial hypertension, heart failure, myocardial infarction, lung transplantation and vascular remodeling.
Targeted qPCR analysis can help researchers investigate disease-associated pathways, validate candidate genes and support translational biomarker studies.
Relevant AnyGenes® solutions:
qPCR remains a key method for validating RNA-seq results, confirming candidate gene expression patterns and supporting publication-ready conclusions.
AnyGenes® supports research teams with validated primer sets, targeted qPCR assays, custom panels and bioinformatics services for biomarker discovery and validation.
Relevant AnyGenes® solutions:
DINCH Exposure Triggers Inflammatory, Oxidative, and Apoptotic Pathways in the Liver of Long-Evans Lactating Rats and Their Offspring
Ínigo-Catalina L. et al.
International Journal of Molecular Sciences, 2024.
Research area: inflammation, oxidative stress, apoptosis, toxicology
Relevant AnyGenes® solutions: pathway-focused qPCR analysis, signaling pathway qPCR arrays
This study illustrates the relevance of targeted gene expression analysis for investigating inflammatory, oxidative and apoptotic pathways in experimental toxicology research.
lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction
Pan-Lizcano R. et al.
PLOS One, 2024.
Research area: lncRNA, cardiovascular disease, biomarker research
Relevant AnyGenes® solutions: lncRNA qPCR assays, biomarker validation, RNA-seq qPCR validation
This publication highlights the importance of targeted lncRNA quantification in cardiovascular biomarker research.
The impact of the EVLP on the lung microbiome and its inflammatory reaction
Grando L. et al.
Transplant International, 2024.
Research area: lung microbiome, inflammation, transplantation
Relevant AnyGenes® solutions: microbiota assays, inflammation qPCR analysis, gene expression profiling
This study is relevant for teams investigating microbiome-associated inflammatory responses in pulmonary and transplantation research.
TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells
Ceron-Codorniu M. et al.
Redox Biology, 2024.
Research area: metabolism, oxidative stress, cellular dysfunction
Relevant AnyGenes® solutions: pathway-focused qPCR arrays, gene expression profiling
This publication illustrates how molecular profiling can help investigate metabolic and stress-related pathways in human cellular models.
Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma
Chikhaoui A. et al.
Scientific Reports, 2022.
Research area: melanoma, inflammation, oncology, immune response
Relevant AnyGenes® solutions: inflammation qPCR arrays, cancer pathway profiling, biomarker validation
This publication connects inflammatory pathway analysis with cancer research and translational dermatology.
The following bibliography includes selected scientific publications using AnyGenes® products and services. These qPCR publications and qPCR array publications are organized by year and cover a broad range of biological applications, including oncology, inflammation, cardiovascular research, microbiome analysis, oxidative stress, apoptosis, lncRNA expression, RNA-seq validation and biomarker discovery.
| Year | Publication | Journal | Research area | Related AnyGenes® solution |
|---|---|---|---|---|
| 2024 | Ínigo-Catalina L. et al. DINCH Exposure Triggers Inflammatory, Oxidative, and Apoptotic Pathways in the Liver of Long-Evans Lactating Rats and Their Offspring. | International Journal of Molecular Sciences, 25(23):13017 | Inflammation / oxidative stress / apoptosis / toxicology | Signaling pathway qPCR arrays / gene expression analysis |
| 2024 | Grando L. et al. The impact of the EVLP on the lung microbiome and its inflammatory reaction. | Transplant International, 37:12979 | Microbiome / inflammation / lung transplantation | Microbiota assays / inflammation qPCR analysis |
| 2024 | Ceron-Codorniu M. et al. TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells. | Redox Biology, 75:103301 | Metabolism / oxidative stress / cellular dysfunction | Gene expression profiling / pathway-focused qPCR analysis |
| 2024 | Larriba E. et al. Identification of new targets for glioblastoma therapy based on a DNA expression microarray. | Computational Biology and Medicine, 179:108833 | Glioblastoma / oncology / therapeutic targets | Biomarker discovery / qPCR validation |
| 2024 | Pan-Lizcano R. et al. lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction. | PLOS One, 19(5):e0304041 | lncRNA / cardiovascular disease / biomarker research | lncRNA qPCR assays / biomarker validation |
| 2024 | Sáez-Martínez P. et al. Dysregulation of RNA-Exosome machinery is directly linked to major cancer hallmarks in prostate cancer: Oncogenic role of PABPN1. | Cancer Letters, 584:216604 | Prostate cancer / RNA biology / oncology | Gene expression analysis / qPCR validation |
| 2024 | Pinto-Hernandez P. et al. miR-29a-3p, a new myokine orchestrating resistance exercise via coordinated metabolic responses. | bioRxiv, 592416 | miRNA / metabolism / exercise biology | qPCR validation / gene expression profiling |
| 2023 | Aragón-Herrera A. et al. The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats. | Biomedicine & Pharmacotherapy, 161:114535 | Metabolism / inflammation / diabetes | Inflammation qPCR arrays / pathway analysis |
| 2023 | Rancan L. et al. Protective Actions of Cannabidiol on Aging-Related Inflammation, Oxidative Stress and Apoptosis Alterations in Liver and Lung of Long Evans Rats. | Antioxidants, 12(10):1837 | Aging / inflammation / oxidative stress / apoptosis | Pathway-focused qPCR arrays |
| 2023 | Masson B. et al. Contribution of transient receptor potential canonical channels in human and experimental pulmonary arterial hypertension. | American Journal of Physiology-Lung Cellular and Molecular Physiology, 325:L246-L261 | Pulmonary arterial hypertension / vascular biology | Cardiovascular pathway qPCR arrays / biomarker research |
| 2023 | Rivas-Chacón L. d. M. et al. Cocoa Polyphenol Extract Inhibits Cellular Senescence via Modulation of SIRT1 and SIRT3 in Auditory Cells. | Nutrients, 15:544 | Cellular senescence / oxidative stress / auditory cells | Gene expression analysis / qPCR validation |
| 2022 | Companys-Alemany J. et al. Glial cell reactivity and oxidative stress prevention in Alzheimer’s disease mice model by an optimized NMDA receptor antagonist. | Scientific Reports, 12(1):17908 | Alzheimer’s disease / neuroinflammation / oxidative stress | Gene expression profiling / pathway qPCR analysis |
| 2022 | del Mar Rivas-Chacón L. et al. Preventive Effect of Cocoa Flavonoids via Suppression of Oxidative Stress-Induced Apoptosis in Auditory Senescent Cells. | Antioxidants, 11:1450 | Oxidative stress / apoptosis / cellular senescence | Oxidative stress and apoptosis qPCR arrays |
| 2022 | Pérez-Carrillo L. et al. Cardiac Sodium/Hydrogen Exchanger as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study. | Pharmaceutics, 14:1996 | Heart failure / cardiovascular disease / drug response | Cardiovascular qPCR analysis / biomarker validation |
| 2022 | To-Figueras J. et al. Transcriptomic study in explanted liver from a patient with acute intermittent porphyria. | JIMD Reports, 64(1):10-16 | Transcriptomics / liver disease / rare disease | RNA-seq validation / gene expression analysis |
| 2022 | Chikhaoui A. et al. Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma. | Scientific Reports, 12(1):13854 | Melanoma / inflammation / immune response | Inflammation qPCR arrays / cancer pathway profiling |
| 2021 | Roglans N. et al. Chronic liquid fructose supplementation does not cause liver tumorigenesis but elicits clear sex differences in the metabolic response in Sprague-Dawley rats. | Food & Nutrition Research, 65 | Metabolism / liver biology / nutritional research | Gene expression analysis / metabolic pathway qPCR |
| 2021 | Chen W. et al. CircRNA circPTK2 Might Suppress Cancer Cell Invasion and Migration of Glioblastoma by Inhibiting miR-23a Maturation. | Neuropsychiatric Disease and Treatment, 17:2767-2774 | Glioblastoma / circRNA / cancer migration | Non-coding RNA qPCR validation |
| 2021 | Reger de Moura C. et al. CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1. | Cancers, 13(19):4859 | Melanoma / lymphangiogenesis / tumor biology | Cancer pathway qPCR analysis / biomarker validation |
| 2021 | Linillos-Pradillo B. et al. Determination of SARS-CoV-2 RNA in different particulate matter size fractions of outdoor air samples in Madrid during the lockdown. | Environmental Research, 195:110863 | SARS-CoV-2 / environmental monitoring / qPCR detection | qPCR detection / molecular analysis |
| 2021 | Garcia P. et al. Disruption of NIPBL/Scc2 in Cornelia de Lange Syndrome provokes cohesin genome-wide redistribution with an impact in the transcriptome. | Nature Communications, 12(1):4551 | Transcriptomics / rare disease / gene regulation | RNA-seq validation / qPCR gene expression |
| 2021 | Vasilopoulou F. et al. Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model. | Genes, 12(9):1315-1327 | Alzheimer’s disease / inflammation / transcriptomics | Inflammation qPCR analysis / transcriptomic validation |
| 2021 | Haijun Wan H. et al. CircRNA CircRIMS is Overexpressed in Esophageal Squamous Cell Carcinoma and Downregulate miR-613 Through Methylation to Increase Cell Proliferation. | Cancer Management and Research, 13:4587-4595 | Esophageal cancer / circRNA / methylation | Non-coding RNA qPCR validation |
| 2021 | Ribó P. et al. Mutation in KARS: A novel mechanism for severe anaphylaxis. | Journal of Allergy and Clinical Immunology, 147(5):1855-1864 | Allergy / anaphylaxis / rare disease | Gene expression analysis / molecular validation |
| 2020 | Bouchet M. et al. ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response. | Cancer Research, 80(13):2914-2926 | Bone metastases / cancer immunology | Cancer and immune response qPCR profiling |
| 2020 | Tétu P. et al. FGF2 Induces Resistance to Nilotinib through MAPK Pathway Activation in KIT Mutated Melanoma. | Cancers, 12(5):1062 | Melanoma / drug resistance / MAPK pathway | Signaling pathway qPCR arrays / cancer research |
| 2020 | Moreno-Rubio J. et al. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer. | Cancer Biology & Medicine, 17(2):444-457 | Non-small cell lung cancer / biomarkers | Biomarker profiling / qPCR validation |
| 2020 | Tong C. et al. Repurposing loperamide to overcome gefitinib resistance by triggering apoptosis independent of autophagy induction in KRAS mutant NSCLC cells. | Cancer Treatment and Research Communications, 25:100229 | NSCLC / apoptosis / drug resistance | Apoptosis qPCR arrays / cancer pathway analysis |
| 2020 | Ataam AJ. et al. Targeted Angiogenesis Gene Expression Profiling of Patients with Chronic Thromboembolic Pulmonary Hypertension. | Journal of Heart and Lung Transplantation, 39(4):S31 | Pulmonary hypertension / angiogenesis | Angiogenesis qPCR arrays / cardiovascular profiling |
| 2020 | Martínez-García MA. et al. TLR2 and TLR4 Surface and Gene Expression in White Blood Cells after Fasting and Oral Glucose, Lipid and Protein Challenges: Influence of Obesity and Sex Hormones. | Biomolecules, 10(1):111 | Inflammation / metabolism / obesity | Inflammatory gene expression analysis |
| 2019 | Reger de Moura C. et al. Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma. | Translational Oncology, 13(2):275-286 | Melanoma / MAPK inhibitors / treatment response | MAPK pathway qPCR analysis / cancer biomarkers |
| 2019 | Louveau B. et al. Baseline Genomic Features in BRAF V600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care. | Cancers, 11(8):E1203 | Melanoma / targeted therapy / genomics | qPCR validation / biomarker analysis |
| 2019 | Dupain C. et al. Newly identified LMO3-BORCS5 fusion oncogene in Ewing sarcoma at relapse is a driver of tumor progression. | Oncogene, 38(47):7200-7215 | Ewing sarcoma / oncogene / tumor progression | qPCR validation / cancer gene expression analysis |
| 2019 | Reger de Moura C. et al. Discoidin Domain Receptors: A promising target in melanoma. | Pigment Cell & Melanoma Research, 32(5):697-707 | Melanoma / therapeutic targets | Cancer pathway qPCR analysis |
| 2019 | Louveau B. et al. A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors. | Oncotarget, 10(18):1669-1687 | Melanoma / BRAF inhibitors / survival biomarkers | Biomarker validation / targeted qPCR analysis |
| 2018 | Félix AJ. et al. Functional pharmacogenomics and toxicity of PolyPurine Reverse Hoogsteen hairpins directed against survivin in human cells. | Biochemical Pharmacology, 155:8-20 | Pharmacogenomics / toxicity / survivin | qPCR validation / gene expression analysis |
| 2018 | Torres RJ. & Puig JG. Aicar effect in early neuronal development. | Nucleosides, Nucleotides and Nucleic Acids, 37(5):261-272 | Neuronal development / metabolism | Gene expression analysis |
| 2018 | Delyon J. et al. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network. | Journal of Investigative Dermatology, 138(1):58-67 | Melanoma / STAT3 / drug response | STAT3 pathway qPCR analysis / biomarker validation |
| 2017 | Mgrditchian T. et al. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. | Proceedings of the National Academy of Sciences, 114(44):9271-9279 | Melanoma / autophagy / immune response | Immune response and cancer qPCR profiling |
| 2017 | Buart S. et al. Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3. | Oncotarget, 8(65):108786-108801 | Melanoma / hypoxia / prognosis | Hypoxia pathway qPCR analysis / biomarker validation |
| 2017 | Broséus J. et al. VEGF121 is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers. | Oncotarget, 8(53):90808-90824 | Lymphoma / VEGF / immune response | Angiogenesis and immune response qPCR analysis |
| 2017 | Delyon J. et al. PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma. | Oncogene, 36(23):3252-3262 | Melanoma / invasion / BRAF mutation | Cancer pathway qPCR analysis / biomarker validation |
| 2017 | Doucet M. et al. Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking. | Biopreservation and Biobanking, 15(3):270-276 | Biobanking / sample quality / research infrastructure | Molecular analysis support / qPCR workflows |
| 2016 | Delyon J. et al. Validation of a preclinical model for assessment of drug efficacy in melanoma. | Oncotarget, 7(11):13069-13081 | Melanoma / preclinical model / drug efficacy | qPCR validation / cancer gene expression |
| 2016 | Xu-Dubois YC. et al. Markers of endothelial to mesenchymal transition: evidence for antibody-endothelium interaction during antibody mediated rejection in kidney recipients. | Journal of the American Society of Nephrology, 27(1):324-332 | Kidney transplantation / endothelial transition / rejection | Endothelial marker qPCR analysis |
| 2015 | Mourah S. et al. Dramatic Transient Improvement of Metastatic BRAF V600E-Mutated Langerhans Cell Sarcoma under treatment with Dabrafenib. | Blood, 126(24):2649-2652 | Sarcoma / BRAF mutation / targeted therapy | qPCR validation / biomarker analysis |
| 2015 | Delyon J. et al. EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells. | Experimental Dermatology, 24(6):443-448 | Melanoma / adhesion / tumor biology | Cancer qPCR analysis / gene expression profiling |
| 2015 | Khayati F. et al. EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF. | Oncotarget, 6(12):9766-9780 | Angiogenesis / VEGF signaling / cancer biology | Angiogenesis qPCR arrays / VEGF pathway analysis |
| 2015 | Ranchoux B. et al. Endothelial-to-mesenchymal transition in pulmonary hypertension. | Circulation, 131(11):1006-1018 | Pulmonary hypertension / endothelial transition | Cardiovascular qPCR arrays / gene expression profiling |
| 2014 | Djaafri I. et al. A novel tumor suppressor function of Kindlin-3 in solid cancer. | Oncotarget, 5(19):8970-8985 | Solid cancer / tumor suppressor / Kindlin-3 | Cancer qPCR validation / gene expression analysis |
| 2014 | Milia-Argeiti E. et al. EMMPRIN/CD147-enriched membrane vesicles released from malignant human testicular germ cells increase MMP production through tumor-stroma interaction. | Biochimica et Biophysica Acta, 1840(8):2581-2588 | Testicular germ cell tumors / MMP / tumor microenvironment | MMP pathway qPCR analysis / cancer gene expression |
| 2012 | Lescaille G. et al. EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression. | BMC Cancer, 12:115 | Oral cancer / tumor progression / uPA pathway | Cancer pathway qPCR analysis |
| 2012 | Milia-Argeiti E. et al. Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours. | International Journal of Andrology, 35(6):835-844 | Testicular germ cell tumors / invasion / MMP-TIMP balance | MMP pathway qPCR analysis / gene expression profiling |
| 2011 | Abdelkarim M. et al. Invading Basement Membrane Matrix Is Sufficient for MDA-MB-231 Breast Cancer Cells to Develop a Stable In Vivo Metastatic Phenotype. | PLOS One, 6(8):e23334 | Breast cancer / metastasis / tumor invasion | Cancer gene expression analysis / qPCR validation |
| 2011 | Huet E. et al. EMMPRIN Modulates Epithelial Barrier Function through a MMP-Mediated Occludin Cleavage: Implications in Dry Eye Disease. | American Journal of Pathology, 179(3):1278-1286 | Epithelial barrier / MMP pathway / dry eye disease | MMP pathway qPCR analysis |
| 2011 | Moreau M. et al. β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells. | International Journal of Cancer, 128(6):1280-1292 | Cancer signaling / NF-κB / uPA-uPAR pathway | Signaling pathway qPCR analysis / cancer profiling |
| 2010 | Bougatef F. et al. EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2. | PLOS One, 5(8):e12265 | Melanoma / hypoxia / VEGF signaling | Hypoxia and angiogenesis qPCR analysis |
| 2010 | Paule B. et al. Soluble Isoforms of Vascular Endothelial Growth Factor Are Predictors of Response to Sunitinib in Metastatic Renal Cell Carcinomas. | PLOS One, 5(5):e10715 | Renal cell carcinoma / VEGF / treatment response | Angiogenesis qPCR analysis / biomarker validation |
| 2010 | Ma L. et al. Antisense Inhibition of Amphiregulin Expression Reduces EGFR Phosphorylation in Transformed Human Breast Epithelial Cells. | Anticancer Research, 30(6):2101-2106 | Breast epithelial cells / EGFR signaling / cancer biology | EGFR pathway qPCR analysis / gene expression validation |
| 2009 | Bougatef F. et al. EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2-mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2. | Blood, 114(27):5547-5556 | Angiogenesis / hypoxia / VEGF signaling | Angiogenesis qPCR arrays / gene expression analysis |
Whether you are validating RNA-seq results, studying signaling pathways, profiling lncRNAs or developing a biomarker strategy, AnyGenes® can help you select the right qPCR assays, qPCR arrays, validated primer sets or custom gene expression solution for your project.
Discuss your project with our scientific teamAnyGenes® SignArrays® are pathway-focused qPCR arrays designed to help researchers analyze targeted biological pathways with a practical, reproducible and publication-oriented workflow. They are particularly relevant for studies involving inflammation, apoptosis, oxidative stress, angiogenesis, immune response, cancer signaling, cardiovascular pathways and translational biomarker research.
AnyGenes® lncRNA qPCR assays support targeted quantification of long non-coding RNAs, including candidate lncRNA biomarkers identified through RNA-seq, literature research or disease-focused discovery projects. They are useful for researchers who need to validate lncRNA expression patterns by qPCR and build focused non-coding RNA panels.
AnyGenes® validated primer sets help researchers perform targeted gene expression analysis for selected genes, pathways, species or custom panels. They can support RNA-seq validation, biomarker confirmation, pathway analysis and focused qPCR experiments.
For low-input RNA, FFPE samples, rare cell populations or single-cell workflows, AnyGenes® offers qPCR master mixes and SpeAmp® pre-amplification solutions designed to support sensitive and reproducible gene expression analysis.
AnyGenes® supports research teams with biomarker identification, qPCR validation, RNA-seq data analysis and customized gene expression workflows. These services are particularly useful for teams that need to move from large-scale transcriptomic data to targeted, validated and biologically interpretable qPCR results.
Published research provides an important trust signal when selecting qPCR assays, qPCR arrays, primer sets or biomarker validation services.
For researchers, qPCR publications help answer practical questions:
By presenting qPCR publications clearly, AnyGenes® helps researchers evaluate the scientific relevance of its products and services before starting a new project.
Whether you are validating RNA-seq results, studying signaling pathways, profiling lncRNAs or developing a biomarker strategy, our scientific team can help you select the most appropriate qPCR solution for your samples, species, genes and research objectives.
AnyGenes® can support your project with: ready-to-use qPCR assays, pathway-focused qPCR arrays, lncRNA qPCR panels, validated primer sets, qPCR master mixes, pre-amplification solutions, RNA-seq qPCR validation, biomarker identification and validation, custom qPCR panel design.
qPCR publications are scientific studies that use quantitative PCR to measure gene expression, validate biomarkers, confirm transcriptomic results or analyze targeted biological pathways.
qPCR array publications are studies that use qPCR arrays or pathway-focused gene panels to analyze multiple genes involved in specific biological processes, such as inflammation, apoptosis, oxidative stress, angiogenesis, cancer signaling or immune response.
Yes. AnyGenes® products and services have been used in peer-reviewed qPCR publications across multiple research areas, including cancer, inflammation, cardiovascular diseases, oxidative stress, microbiome research, lncRNA analysis and biomarker discovery.
Published studies may involve different AnyGenes® solutions, including SignArrays® qPCR arrays, lncRNA qPCR assays, validated primer sets, qPCR master mixes, pre-amplification kits, microbiota assays and biomarker services.
Yes. AnyGenes® provides qPCR solutions and services that can support RNA-seq validation, including validated primer sets, lncRNA assays, pathway-focused panels and customized qPCR workflows.
Yes. AnyGenes® can support custom qPCR panels based on selected genes, biological pathways, species, sample types or candidate biomarkers.